Published in J Infect Dis on January 01, 1973
The rôle of Chlamydia trachomatis in genital-tract and associated diseases. J Clin Pathol (1980) 6.42
Failure of serology in diagnosing chlamydial infections of the female genital tract. J Clin Microbiol (1979) 3.27
Human cell-mediated immune responses to chlamydial antigens. Infect Immun (1979) 1.76
Antichlamydial antibody in tears and sera, and serotypes of Chlamydia trachomatis isolated from schoolchildren in Southern Tunisia. Br J Ophthalmol (1978) 1.20
Spectrum of human chlamydial infections. West J Med (1981) 1.13
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
Severe endemic trachoma in tunisia. II. A controlled therapy trial of topically applied chlortetracycline and erythromycin. Arch Ophthalmol (1974) 6.79
Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull World Health Organ (1975) 5.58
Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79
Severe endemic trachoma in Tunisia. Br J Ophthalmol (1976) 4.35
Azithromycin in control of trachoma. Lancet (1999) 4.32
The Combined Action of Penicillin with Streptomycin or Chloromycetin on Enterococci in Vitro. Science (1950) 3.64
Experimental Infection of the Chick Embryo with Virulent and Avirulent Pasteurella Pestis. Am J Pathol (1944) 3.50
Titration and typing of serum antibodies in TRIC infections by immunofluorescence. J Immunol (1972) 3.17
Emergence of rifampin-resistance in Chlamydia trachomatis. Nature (1973) 3.06
The use of combinations of antimicrobial drugs. Annu Rev Pharmacol (1968) 2.94
Inhibition of TRIC agents by virus-induced interferon. Proc Soc Exp Biol Med (1966) 2.78
Latency in human infections with TRIC agents. J Immunol (1968) 2.73
Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol (1991) 2.67
Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia. Am J Ophthalmol (1975) 2.66
Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis (1988) 2.47
Severe endemic trachoma in Tunisia. I. Effect of topical chemotherapy on conjunctivitis and ocular bacteria. Br J Ophthalmol (1974) 2.23
Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis (1992) 2.21
Inhibition of antichlamydial IgM antibody by IgG antibody in immunofluorescence tests. J Immunol (1972) 2.20
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance. JAMA (1965) 1.97
The floppy eyelid syndrome. Am J Ophthalmol (1981) 1.95
Doxycycline treatment of chronic trachoma. JAMA (1973) 1.89
Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro. Appl Microbiol (1969) 1.89
Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology (1994) 1.88
Evaluation of laboratory methods for detecting acute TRIC agent infection. Am J Ophthalmol (1970) 1.77
Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation. N Engl J Med (1966) 1.76
Human cell-mediated immune responses to chlamydial antigens. Infect Immun (1979) 1.76
Antibiotic susceptibility of Chlamydia trachomatis. Antimicrob Agents Chemother (1977) 1.76
Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis. Antimicrob Agents Chemother (1975) 1.74
The interaction of bee melittin with lipid bilayer membranes. Biochim Biophys Acta (1978) 1.73
Combined antibiotic action: some definitions and correlations between laboratory and clinical results. Antimicrob Agents Chemother (Bethesda) (1967) 1.73
Type-specific antibodies in human Chlamydia trachomatis infections of the eye. J Immunol (1974) 1.73
Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol (1976) 1.71
Chemotherapy of chlamydial infections. Adv Pharmacol Chemother (1969) 1.68
Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology (1994) 1.68
Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population. Br J Ophthalmol (1989) 1.66
Bacteriologic studies of a trachomatous population. Am J Ophthalmol (1967) 1.61
Studies on herpes simplex. XI. The antiviral dynamics of 5-iodo-2-deoxyuridine in vivo. J Immunol (1965) 1.59
The challenge of patients' unmet palliative care needs in the final stages of chronic illness. Palliat Med (2007) 1.54
Lymphogranuloma venereum. I. Comparison of the Frei test, complement fixation test, and isolation of the agent. J Infect Dis (1969) 1.52
Comparison of media for the isolation of haemophilus species from cases of seasonal conjunctivitis associated with severe endemic trachoma. Appl Microbiol (1974) 1.51
Cytology as a guide to the presence of chlamydial inclusions in Giemsa-stained conjunctival smears in severe endemic trachoma. Br J Ophthalmol (1975) 1.47
'I can't do any serious exercise': barriers to physical activity amongst people of Pakistani and Indian origin with Type 2 diabetes. Health Educ Res (2005) 1.46
An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci (1981) 1.44
Adenovirus type 8 keratoconjunctivitis in the United States. 3. Epidemiologic, clinical, and microbiologic features. Am J Ophthalmol (1970) 1.42
Training in clinical oncology: results of the Royal College of Radiologists' survey of new consultants. Clin Oncol (R Coll Radiol) (2012) 1.41
Small cell lung cancer treated in southeast Wales. Clin Oncol (R Coll Radiol) (2006) 1.40
Synergism and antagonism among antimicrobial drugs. A personal perspective. West J Med (1975) 1.38
The taxonomy of haemophili isolated from conjunctivae. Acta Pathol Microbiol Scand B (1976) 1.37
Human infection with the agent of feline pneumonitis. Lancet (1969) 1.35
The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis Suppl (1990) 1.34
Chlamydiae, cervicitis, and abnormal Papanicolaou smears. Obstet Gynecol (1979) 1.30
Characteristics of interferon induced in vitro and in vivo by a TRIC agent. Proc Soc Exp Biol Med (1966) 1.29
Demonstration of the mucous layer of the tear film by electron microscopy. Invest Ophthalmol Vis Sci (1985) 1.28
Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol (1991) 1.28
Trachoma and follicular conjunctivitis in children. Arch Ophthalmol (1966) 1.27
Protective effect of a synthetic polynucleotide complex (poly I: C) on ocular lesions produced by trachoma agent in rabbits. Infect Immun (1970) 1.26
Strategies for treatment and control of blinding trachoma: cost-effectiveness of topical or systemic antibiotics. Rev Infect Dis (1986) 1.26
Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest Ophthalmol Vis Sci (1992) 1.23
TRIC agent infections of the eye and genital tract. Am J Ophthalmol (1967) 1.22
Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat (2000) 1.21
Economic effects of community versus hospital-based faculty pneumonia care. J Gen Intern Med (1998) 1.20
Antibodies to TRIC agents in matched human tears and sera. J Immunol (1973) 1.19
Adenovirus type 8 infections in the United States. IV. Observations on the pathogenesis of lesions in severe eye disease. Arch Ophthalmol (1972) 1.19
Resistance to reinfection with a chlamydial agent (guinea pig inclusion conjunctivitis agent). Invest Ophthalmol Vis Sci (1977) 1.16
Isolation and Characteristics of Bacteriophages for Staphylococci of Bovine Mastitis. J Bacteriol (1941) 1.15
Immunofluorescence in chronic TRIC infections of American Indians and Tunisians: influence of trauma on results of tests. Proc Soc Exp Biol Med (1971) 1.12
New view of the surface projections of Chlamydia trachomatis. J Bacteriol (1985) 1.12
Immune responses to chlamydial antigens in humans. Med Microbiol Immunol (1982) 1.11